BeStock  
Stocks › Biotechnology › INCY

Incyte INCY

US equityMarket cap rank #509BiotechnologyCAR-T Therapy
$119.39 −$1.96 (-1.62%)
Market open · Oct 1, 11:50 am ET · After hours $121.35 0.00%
Open$120.47
Prev close$121.35
Day range$119.02 – $121.22
Volume525.5K
Market cap$24.20B
P/E (TTM)15.2
Dividend yield–

INCY Stock News

Headlines matching Incyte or the INCY ticker, most recent first.

  • H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $152Market news · 29 Sep 2026
  • HC Wainwright & Co. Maintains Buy on Incyte, Raises Price Target to $152Benzinga · 28 Sep 2026
  • H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $152Market news · 28 Sep 2026
  • H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $150Market news · 1 Sep 2026
  • BMO Capital Maintains Incyte(INCY.US) With Hold Rating, Maintains Target Price $130Market news · 1 Sep 2026
  • HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $150 Price TargetBenzinga · 3 Aug 2026
  • Mizuho Securities Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $137Market news · 3 Aug 2026
  • Leerink Partners Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $155Market news · 3 Aug 2026
  • CCORF Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $152Market news · 21 Aug 2026
  • CCORF Initiates Incyte(INCY.US) With Buy Rating, Announces Target Price $152Market news · 20 Aug 2026
  • William Blair Maintains Incyte(INCY.US) With Hold RatingMarket news · 20 Aug 2026
  • Piper Sandler Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $130Market news · 17 Aug 2026
  • H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $150Market news · 30 Jul 2026
  • 4: Incyte | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LPSEC · 3 Jul 2026
  • BMO Capital Upgrades Incyte(INCY.US) to Hold Rating, Raises Target Price to $130Market news · 29 Jul 2026

Discussion

No comments yet — be the first to weigh in on INCY.

Leave a comment

Scroll to Top